My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Shree Ajit Pulp And Paper gets reaffirmation of credit ratings
Mar 08,2017

Shree Ajit Pulp And Paper announced that ICRA has re-affirmed its rating A- (ICRA A Minus) for Long Term Rating and A2+ (ICRA A Two Plus) for Short Term Rating of the Company. The outlook has been revised from Stable to Negative.

Powered by Capital Market - Live News

Board of Saianand Commercial appoints directors
Mar 08,2017

Saianand Commercial announced that the Board of Directors of the Company at its meeting held on 08 March 2017 considered the following - To appoint Vikram Champaklal Sanghvi, Jitendra Babulal Shah and Karishma Vikram Sanghvi as additional directors of the Company with effect from 08 March 2017.

Powered by Capital Market - Live News

Board of Puravankara approves change in CFO
Mar 08,2017

Puravankara announced that the Board of Directors of the Company at its meeting held on 08 March 2017 approved the following -

Kuldeep Chawla has been appointed as Chief Financial Officer with effect from 08 March 2017.

The Board placed on record the resignation of Hari Ramakrishnan from the position of Chief Financial Officer of the Company, w.e.f. 08 March 2017.

Powered by Capital Market - Live News

Board of Mawana Sugars agrees to enter into one time settlement for resolution of debt
Mar 08,2017

Mawana Sugars announced that the Board of Directors of the Company vide resolution dated 08 March 2017 has agreed to enter into one time settlement with State Bank of Mysore, New Delhi for resolution of debt, settling Companys total dues of Rs 47.76 lakh, for a consolidated agreed amount of Rs 38 lakh.

Powered by Capital Market - Live News

Axis Rail India appoints CFO
Mar 08,2017

Axis Rail India announced that the Board of Directors of the company at its meeting held on 08 March 2017 has considered and approved the appointment of P.Venu Gopal Reddy as a Chief Financial Officer of the Company w.e.f., 8 March 2017.

Powered by Capital Market - Live News

Outcome of board meeting of Sun Techno Overseas
Mar 08,2017

Sun Techno Overseas announced that the Board of Directors of the company at its meeting held on 08 March 2017 considered the following -

To appoint Rakesh Bhailalbhai Patel and Rakesh Tewari as additional directors in the board of director of the Company.

Powered by Capital Market - Live News

Satin Creditcare Network to hold board meeting
Mar 08,2017

Satin Creditcare Network will hold a meeting of the Board of Directors of the Company on 10 March 2017, to consider Increase in Authorized Share Capital of the Company, consider further issuance of Securities on private placement basis, to persons belonging to promoter/non promoter category, in compliance with applicable rules and regulations. and to decide about the EGM date and other requisite details.

Powered by Capital Market - Live News

Vista Pharmaceuticals to hold EGM
Mar 08,2017

Vista Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 30 March 2017 .

Powered by Capital Market - Live News

Federal Bank appoints Part Time Chairman
Mar 08,2017

Federal Bank announced that RBI has accorded approval vide its letter dated 07 March 2017, for appointing K M Chandrasekhar, who is a Director on the Board of the Bank, as Part Time Chairman of the Bank for a period of one year, effective from 01 March 2017.

Powered by Capital Market - Live News

Hindalco Industries announces closure of QIP issue
Mar 08,2017

Hindalco Industries announced that in respect of the QIP, the Capital Raising Committee of the Company at its meeting held on 08 March, 2017 has, inter alia, passed the following resolutions:

a. Approved the closure of the issue period for the QIP on 08 March 2017;

b. Determined and approved the Issue price of Rs. 189.45/- per Equity Share (including a premium of Rs. 188.45/- per Equity Share). [The Floor Price is Rs. 184.45/- per Equity Share determined as per the formula prescribed under Regulation 85(1) of the SEBI ICDR Regulations for the Equity Shares to be allotted to eligible qualified institutional buyers in the QIP]; and

c. Approved and adopted the placement document dated 08 March 2017, in connection with the QIP.

Powered by Capital Market - Live News

Firstsource Solutions allots 750,000 equity shares
Mar 08,2017

Firstsource Solutions has allotted 750,000 Equity shares of Rs.10/- each bearing distinctive numbers 680,036,638 to 680,786,637 on March 03, 2017, under Employee Stock Option Scheme 2003 of the Company. Consequent to the said allotment, the paid up capital of the Company has increased to Rs. 6,807,866,370 consisting of 680,786,637 Equity shares of Rs.10/- each.

Powered by Capital Market - Live News

Chartered Logistics bags order worth Rs 6.3 crore
Mar 08,2017

Chartered Logistics has bagged order worth Rs 6.3 crore from GHCL to be completed in three months. Up on completion, the company expects orders worth Rs 15 crore from GHCL to be completed in 9 months.

Powered by Capital Market - Live News

NTPC commissions 45 MW of Bhadla Solar Power Project
Mar 08,2017

NTPC announced that 45 MW of Bhadla Solar Power Project of NTPC has been commissioned. With this, the installed capacity of Bhadla Solar Power project has become 160 MW and that of NTPCs solar power projects has become 520 MW. The total installed capacity of NTPC on standalone basis has become 41222 MW and that of NTPC group has become 48188 MW.

Powered by Capital Market - Live News

Board of Hexaware Technologies approves scheme of amalgamation
Mar 08,2017

Hexaware Technologies announced that the Board of Directors at its meeting held on 08 March 2017 has approved scheme of amalgamation of Risk Technology International, a wholly owned subsidiary of Hexaware Technologies with Hexaware, subject to requisite approvals.

Powered by Capital Market - Live News

Unichem Laboratories receives ANDA approval for Rizatriptan Benzoate ODT &
Mar 08,2017

Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (USFDA) for Rizatriptan Benzoate ODT 5mg & 10mg and Rizatriptan Benzoate Tablets USP, 5mg & 10mg which are therapeutically equivalent to Maxalt - MLT Tablets 5mg & 10mg and Maxalt Tablets 5mg 10mg of Merck & Company, Inc.

Rizatriptan Benzoate Tablets USP, 5mg & 10mg and Rizatriptan Benzoate ODT USP, 5mg & 10mg; is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine in adults and in pediatric patients 6 to 17 years of age.

The product will be commercialized from Unichems Goa plant. Active Pharmaceutical Ingredient will also be made in house at Roha API Plant.

Powered by Capital Market - Live News